Vaccine Efficacy

UF biostatisticians confirm in a recent meta-analysis that getting vaccinated against COVID-19 and getting a booster or two is the best way to protect against severe outcomes.

UF investigators participate in the first study to determine that the CoronaVac vaccine is 50% effective at preventing COVID-19 in Manaus, Brazil where the P.1 variant is widespread.

The first approved dengue vaccine may increase the incidence of more severe disease if used in populations with low dengue transmission.

Implementing a vaccine trial during an epidemic can be difficult, particularly in countries with poor transportation, limited vaccine supplies and difficulty predicting how widespread a disease may become — conditions such as those in West Africa during the recent Ebola outbreak.